Ruli, T.M., Jr.; Pollack, E.D.; Lodh, A.; Evers, C.D., III; Price, C.A.; Shoreibah, M.
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma and Their Hepatic-Related Side Effects: A Review. Cancers 2024, 16, 2042.
https://doi.org/10.3390/cancers16112042
AMA Style
Ruli TM Jr., Pollack ED, Lodh A, Evers CD III, Price CA, Shoreibah M.
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma and Their Hepatic-Related Side Effects: A Review. Cancers. 2024; 16(11):2042.
https://doi.org/10.3390/cancers16112042
Chicago/Turabian Style
Ruli, Thomas M., Jr., Ethan D. Pollack, Atul Lodh, Charles D. Evers, III, Christopher A. Price, and Mohamed Shoreibah.
2024. "Immune Checkpoint Inhibitors in Hepatocellular Carcinoma and Their Hepatic-Related Side Effects: A Review" Cancers 16, no. 11: 2042.
https://doi.org/10.3390/cancers16112042
APA Style
Ruli, T. M., Jr., Pollack, E. D., Lodh, A., Evers, C. D., III, Price, C. A., & Shoreibah, M.
(2024). Immune Checkpoint Inhibitors in Hepatocellular Carcinoma and Their Hepatic-Related Side Effects: A Review. Cancers, 16(11), 2042.
https://doi.org/10.3390/cancers16112042